Clinical Trial Update: A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A randomized trial evaluating Ampyra for gait impairment in Parkinson's disease has completed Phase 1 and Phase 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ampyra (4-aminopyridine)

Snippet

Sponsor: University of Miami | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-13